tyrosine has been researched along with dactolisib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Byrne, AT; Dicker, P; Faber, C; Hermann, S; Jacobs, AH; Jarzabek, MA; Klasen, T; Kopka, K; Murray, DW; O'Brien, D; O'Halloran, PJ; Prehn, JH; Schäfers, M; Schwegmann, K; Viel, T; Wachsmuth, L; Wagner, S | 1 |
1 other study(ies) available for tyrosine and dactolisib
Article | Year |
---|---|
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers.
Topics: Animals; Bevacizumab; Biological Transport; Biomarkers, Tumor; Cell Line, Tumor; Drug Interactions; Female; Glioblastoma; Humans; Imidazoles; Magnetic Resonance Imaging; Mice; Microvessels; Multimodal Imaging; Phosphoinositide-3 Kinase Inhibitors; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinolines; TOR Serine-Threonine Kinases; Tumor Burden; Tyrosine; Xenograft Model Antitumor Assays | 2016 |